Healthcare -
Biotechnology - NASDAQ - US
$ 0.344
-0.52 %
$ 17.1 M
Market Cap
-0.17
P/E
Price Target
Average
5049.50%
Revenue Forecast
Estimate
133.64%
EBIT
Estimate
26.42%
Net Income
Estimate
56.10%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioXcel Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for BTAI of $17.7 , with forecasts ranging from
a
low of
$1 to a high of $73 .
BTAI Lowest Price Target
Wall Street Target
1 USD
190.70%
BTAI Average Price Target
Wall Street Target
17.7 USD
5049.50%
BTAI Highest Price Target
Wall Street Target
73 USD
21120.93%
REVENUE FORECAST
Revenue Forecast Chart BTAI
EBIT FORECAST
EBIT Forecast Chart BTAI
NET INCOME FORECAST
Net Income Chart BTAI